HTD News and Press, John Hancock Tax Advantaged Dividend Income Fund of Beneficial Interest From 01/08/24

MENLO PARK, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncology, metabolism and neurology disorders by modulating the effects of the hormo...

2024-01-06 10:13:00 ET Summary I have a total of 41 positions in my closed-end fund portfolio, with the top ten positions making up 36.52% of the portfolio. We have four new names making their way to my top ten list since the prior update, but three were already positions that hav...

2024-01-02 21:31:55 ET Summary Total Return is the actual rate of return for an investment over a given evaluation period, typically one, three, five, or ten years. The Total NAV Return is the sum of all dividends/distributions, assuming they are reinvested, plus the change in the...

MENLO PARK, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncology, metabolism, and neurology disorders by modulating the effects of the horm...

2023-12-15 04:38:41 ET John Hancock Financial Opportunities Fund ( NYSE: BTO ), John Hancock Hedged Equity & Income Fund ( NYSE: HEQ ), John Hancock Income Securities Trust ( NYSE: JHS ), John Hancock Investors Trust ( NYSE: JHI ), John Hancock Premium ...

2023-12-13 05:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-11-28 07:26:26 ET Summary John Hancock Premium Dividend Fund cut its distribution earlier this year, leading to a sell-off, but the discount/premiums of closed-end funds can be exploited by investors. PDT's discount has narrowed since the distribution cut pushed it to a wide ...

2023-11-07 07:55:10 ET Summary The John Hancock Tax-Advantaged Dividend Income Fund aims to provide high current income and capital gains through investments in common equity. The fund has underperformed the S&P 500 Index over the past two months but has only lost 5.14% for in...

MENLO PARK, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncology, metabolism and neurology disorders by modulating the effects of the hormo...

MENLO PARK, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncology, metabolism, and neurology disorders by modulating the effects of the horm...